# Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate

> **NCT02934594** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Neoplasm Metastasis
- Spinal Cord Compression

## Interventions

- **OTHER:** Palliative Decompression

## Key facts

- **NCT ID:** NCT02934594
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2020-08
- **Final completion:** 2020-08
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2016-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934594, "Metastatic Spinal Cord Compression (MSCC): Treatment Timing and Survival Rate". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02934594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*